Acute Effects of Canagliflozin, a Sodium Glucose Co-Transporter 2 (SGLT2) Inhibitor on Bone Metabolism in Healthy Volunteers
Clinical trial NCT02404870 · COMPLETED
Trial details
- NCT number
- NCT02404870
- Sponsor
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-09-16
- Primary completion
- 2019-05-01
- Enrollment
- 67
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.